ARCHIVES

Leter: Payers Must Determine Appropriate Therapies

This article is from The Cancer Letter archive.

Vol. 22 No. 29 | July 19, 1996

Download PDF Visit The Full Archive

Related Articles

Analysis Reveals CAIX Subgroup Responsive to Rencarex Therapy

June 28, 2013

Existing HER2 Drugs May Help More In Breast Cancer Treatment

January 25, 2013

Two-Point Rise In PSA Signals High-Risk Prostate Cancer

August 26, 2005

Cancer Care Uneven, IOM’s National Cancer Policy Board Concludes

April 9, 1999

Cancer Control Survey Determines Manpower Needs for Quality Care

July 9, 1976

“I Can’t Permit Destruction of NSABP,” Fisher Writes

September 9, 1994